Alerts & notifications
-
2C-B misrepresented as MDMA in DunedinNotification|21 June 2024
2C-B has been detected in a pinkish/purple powder presumed to be MDMA in the Dunedin area
-
Highly potent synthetic opioid detected in fake diazepam tabletNotification|06 May 2024
UPDATED 6 May 2024
A highly potent synthetic opioid, N-Desethyletonitazene, has been detected in a fake benzodiazepine tablets. -
Synthetic Cannabinoid misrepresented as DMTNotification|03 May 2024
UPDATED 3 May 2024
Synthetic Cannabinoid MDMB-4en-PINACA has been detected in a yellow powder presumed to be DMT -
Highly potent synthetic opioid misrepresented as butonitazeneNotification|03 November 2023
More highly potent nitazene variations have been identified.
-
Fake oxycodone tablets linked to serious harmNotification|27 September 2023
Fake oxycodone tablets, containing metonitazene, may be linked to a recent death and serious hospitalisations in New Zealand
-
Synthetic cannabinoid harm in Christchurch linked to hospitalisationsNotification|10 November 2022
A particularly dangerous batch of synthetic cannabinoids has been linked to serious harm in Christchurch in November 2022.
-
Yellow tablet/powder containing potent opioid likely to cause serious harmNotification|21 October 2022
UPDATED 28 MARCH 2023
Serious harm has been identified in relation to metonitazene found in a yellow powder. High Alert urges continued caution, particularly in the Auckland region. -
Synthetic cannabinoid harm in TaranakiNotification|05 July 2021
A particularly dangerous batch of synthetic cannabinoids is currently present in Taranaki.
-
Serious synthetic cannabinoids harm in Christchurch linked to 4F-MDMB-BINACA and MDMB-4en-PINACANotification|26 February 2021
A dangerous batch of synthetic cannabinoids is currently present in Christchurch in February 2021.
-
Serious incidents linked to synthetic cannabinoids in TaranakiNotification|02 October 2020
A number of harm incidents involving synthetic cannabinoids have occurred in the Taranaki region.